Recent findings Recent evidence supports the role of the sympathetic nervous system in the regulation of HSC behavior, both directly and through supporting stromal cells. In addition, the sympathetic nervous system transduces circadian information from the central pacemaker in the brain, the suprachiasmatic nucleus, to the bone marrow microenvironment, directing circadian oscillations in hematopoiesis and HSC migration. Summary HSC traffic and hematopoiesis do not escape the circadian regulation that controls most physiological processes. Clinically, the timing of stem cell harvest or infusion may impact the yield or engraftment, respectively, and may result in better therapeutic outcomes.
Introduction
Circadian (from latin circa diem, meaning 'about a day') rhythms allow the organism to anticipate its daily needs and accordingly modulate its physiology and behavior. The ability to anticipate future needs has provided a clear adaptative advantage, such that circadian clocks have been conserved throughout evolution from the unicellular diazotrophic cyanobacteria, which exhibit daily rhythms in nitrogen fixation, to more complex organisms. In mammals, light signals detected from the retina entrain circadian rhythms to the daylight cycle that affect most physiological processes, including sleep, hormone secretion, cell cycle, and immunity. Other species are adapted to sense different environmental cues; for example, crustaceans and fish display circatidal activities related to rhythmic ($12 h) tidal flooding and ebbing [1] . Despite its buried location inside the skeleton, the hematopoietic system is not spared from circadian influence. In this article, we will briefly review the evidence for circadian oscillations in proliferation and migration of hematopoietic stem and progenitor cells and the possible underlying mechanisms.
The molecular clock
Circadian rhythms are sustained at the molecular level by asynchronous expression of the so-called 'clock genes' that interact in feedback loops. At the organismal level, the suprachiasmatic nucleus (SCN) localized in the anterior hypothalamus is the central pacemaker that regulates oscillations in multiple peripheral tissues. The central clock is entrained by photic cues transmitted through the retinal-hypothalamic tract, allowing for the daily reset of circadian oscillations. The molecular basis for the circadian clock centers on the basic principle that in the SCN, and also in multiple peripheral tissues, the expression of a group of clock genes (Bmal1, Clock and Npas2) occurs asynchronously with the transcription of other genes (Cry1, Cry2, Per1, Per2, Rev-erb-a and Rev-erbb) that form feedback loops ( Fig. 1 [2, 3] ). The basic mechanism of circadian gene expression involves the translation of Bmal1 and Clock, which results in heterodimerization of the protein products and their and binding to E-boxes on the promoters of genes undergoing timed fluctuations and also other clock genes that in turn extinguish the expression of Bmal1 and Clock. This yields Purpose of review Hematopoiesis is tightly regulated in the bone marrow through the microenvironment, soluble factors from the circulation, and neural inputs from the autonomic nervous system. Most physiological processes are not uniform but rather vary according to the time of day. There is increasing evidence showing the impact of biological rhythms on the traffic of hematopoietic stem cells (HSCs) and their proliferation and differentiation capacities.
autoregulatory loops that occur approximately in 24-h cycles. In addition to these transcriptional fluctuations, the expression of clock genes is also regulated by posttranscriptional, posttranslational, and epigenetic mechanisms such as phosphorylation, ubiquitination, and chromatin remodeling [4 ] . In addition to the light signals, other physiological cues can regulate the central clock. For example, when food is only available during the normal sleep period, rhythms are reset in the dorsomedial hypothalamus such that the active period corresponds to the period of food availability [5 ] .
Core clock gene expression is not restricted to the SCN; most cells of the body in fact express clock genes. It is thought that the central clock synchronizes these peripheral oscillators in a hierarchical fashion. It has been estimated that up to 10% of the genes in any tissue are composed of clock-controlled genes [6 ] . Studies using conditional repression of Bmal1 transcription in hepatocytes have revealed that most rhythmically active genes depend on an intact liver oscillator, whereas another class of genes fluctuated from central clock signals [7] . Bone remodeling also depends on the expression of clock genes by the osteoblast, which suppresses the expression of G1 cyclins and osteoblast proliferation [8] . Although clock gene expression has clearly been documented in the bone marrow [9, 10 ] and in hematopoietic stem cells (HSCs) [11, 12] , it is not yet clear whether, and if so how, these oscillations impact hematopoiesis.
Circadian oscillations of progenitor activity in the bone marrow
Several studies have documented circadian oscillations in the rate of DNA synthesis and the colony-forming ability in the bone marrow of humans and mice [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] ( Table 1 ). In humans, bone marrow colony-forming units-granulocyte-macrophage (CFU-GM) exhibit significant circadian oscillations that peak shortly after noon [14, 17] . Interestingly, this coincides with the peak in DNA synthesis, raising the possibility that HSC proliferation and differentiation into committed progenitors may follow circadian variations. Strikingly, a six-fold peak-trough difference in the number of CD34 þ cells 236 Hematopoiesis Figure 1 Basic schematic of the molecular circadian oscillating network in mammals Transcripts of the central clock genes, Bmal1 and Clock, or its related protein Npas2, are transported to the cytosol, translated, and the protein products form heterodimers. These BMAL1-CLOCK heterodimers translocate back into the nucleus and bind to canonical E-box sequences (CACCTG) to activate transcription of clock-controlled genes that mediate circadian processes. BMAL1-CLOCK activation of retinoic acid orphan receptor (Ror) transcription and translation feeds-forward the circadian clock by binding the RREs on the promoter of Bmal1. Negative feedback occurs by initiating transcription of the clock genes, Period (Per) and Crytochrome (Cry), whose protein products heterodimerize and thwart BMAL1-CLOCK interaction in the nucleus and activating transcription of Rev-erb, whose protein product competes with the positive regulator, ROR, for RRE binding. Black arrows depict feed-forward loops, whereas grey arrows label negative feedback loops. Not depicted above are the posttranslational modifications that regulate protein stability and nuclear translocation that are critical for maintenance of 24-h rhythms. Ccg, clock-controlled genes; Cry, Crytochrome; Per, Period; Ror, retinoic acid orphan receptor; RRE, retinoic acid receptor element. has been found in the human bone marrow, with the acrophase around noon [17] . Studies on different mouse strains have shown 24-h circadian oscillations in progenitor activity (Table 1) . However, there is a wide variability across the studies, with two separate acrophases of progenitor activity: one possible peak shortly after the onset of light (the beginning of the murine rest phase) and one during the night (the latter part of the murine activity span). As in humans, these peaks appear to overlay with the acrophases of DNA synthesis in the bone marrow (Table 1 ). These changes of DNA synthesis are suggested to have clinical relevance. For example, differential circadian fluctuations in DNA synthesis between host and tumor cells may maximize antisarcoma responses of fluorouracil while minimizing toxicity to the gut and bone marrow [28] . Moreover, a circadian variability in engraftability of congenic bone marrow following sublethal bone marrow transplant has been described, with the nadirs associated with the highest proportion of bone marrow cells in S phase, suggesting that the circadian-regulated DNA synthesis in bone marrow cells may result in diurnal variability in engraftability [29] .
However, when analyzing circadian oscillations in the number of cells, it is important to consider the possible oscillation in the expression of the markers utilized to identify those populations. Hence, oscillations in the expression of surface markers could be erroneously interpreted as variations in bone marrow cell numbers. Similarly, fluctuations in the expression of receptors that determine the in-vitro responsiveness to cytokines and growth factors in colony-forming assays might impact the progenitor activity and might not reflect the in-vivo situation. Indeed, the ability to increase murine colony yield with interleukin (IL)-3, granulocyte colony-stimulating factor (G-CSF), or granulocyte-macrophage colony-stimulating factor (GM-CSF) was maximal 3 h after the onset of light when administered into CFU cultures, suggesting a circadian expression of receptors to these cytokines [26] . Therefore, in the absence of complementary in-vivo approaches, the data regarding oscillations in cell numbers or activities in culture should be interpreted with caution.
The mechanisms behind the fluctuations in bone marrow progenitor activity or cell cycling are unclear. As is the case with any rhythmic activity in peripheral organs, it is important to consider the possible contribution of the sympathetic nervous system (SNS), humoral factors, or an intrinsic oscillator.
Possible contribution of the sympathetic nervous system
The SCN regulates circadian oscillations of multiple tissues through its autonomic output. Anatomically dis-tinct presympathetic and preparasympathetic neurons have been identified in the SCN [30] . A role for the SNS is supported by the diurnal patterns of epinephrine and norepinephrine levels in the blood and urine of humans [31] [32] [33] , indicating that the activity of the SNS undergoes circadian rhythms. Norepinephrine can be secreted directly from nerve terminals or from the adrenal medulla, whereas epinephrine is only synthesized in the adrenal medulla (4 : 1 ratio over norepinephrine). SNS responses typically show regional variability, with the sympathetic outflow to some organs being activated but unchanged or inhibited to other regions [34] . A role for the SNS in the relay of signals from the SCN to peripheral tissues was first demonstrated in the liver, where electrical stimulation of the sympathetic nerves or epinephrine injection caused an elevation of bioluminescence in the liver area of transgenic mice carrying the luciferase gene downstream of the mPer1 promoter [35] . It was first suggested in 1972 that b-adrenergic signaling is required for circadian oscillations in the DNA synthesis of putative HSCs [36] . In the mouse bone marrow, norepinephrine and dopamine, but not epinephrine levels, display a circadian rhythmicity, peaking at night, that is sensitive to pharmacological sympathectomy with 6-hydroxydopamine (6-OHDA) and is positively correlated with the proportion of bone marrow in G2/M and S phase [37] . It is important to point out that plasma or tissue levels of norepinephrine are influenced by norepinephrine clearance, reuptake, and degradation and therefore do not directly reflect SNS activity [34] . Measurements of regional spillover of norepinephrine from organs to venous circulation and microneurography, which are more accurate estimates of organ-specific SNS function [38] , have not been performed in the bone marrow. Administration of norepinephrine is able to protect mice from an otherwise lethal dose of carboplatin by stimulating bone marrow proliferation [39] . This indicates that the central SCN may regulate hematopoiesis through b-adrenergic receptor signaling, and the acrophases in bone marrow DNA synthesis may result from peaks in sympathetic tone. However, it should also be noted that earlier studies have reported that a-adrenergic receptors are present in the bone marrow, and administration of norepinephrine causes a tonic inhibition of myelopoiesis [40, 41] , reversible with a1-adrenergic antagonists. This tonic inhibition by norepinephrine was confirmed by suppression of CFU-GM. These opposite effects of norepinephrine on hematopoiesis have not been clarified further.
Possible contribution of humoral factors
There are numerous candidates that could theoretically affect progenitor growth and behavior in the bone marrow. One obvious class of hormones is glucocorticoids, which are produced in the adrenal cortex and regulate homeostatic functions in many vertebrate tissues, including the response to stress. Pharmacological dexamethasone treatment induces the expression of clock genes in cultured human and murine bone marrow stromal cells [42] , rat fibroblasts and also phase shift expression in the liver, kidney, and heart of mice but not in SCN neurons [43] . These findings suggest that glucocorticoids may be a physiologically important entraining molecule of peripheral clock genes. Interestingly, adrenalectomized rats placed in a 12-h phase shift of light, or jet lag, demonstrated a more rapid adjustment and restoration of rhythms [44] . Thus, under constant lighting conditions, the authors concluded that corticosterone serves to stabilize photoperiod variations in the circadian timing system. This might represent an evolutionary advantage to prevent mammalian clocks from being entrained too easily by transient stimuli. In humans, the inflammatory cytokines interferon-g, tumor necrosis factor-a, IL-1, and IL-12 were found to peak in circulation in the early morning, prior to the acrophase of cortisol that counteracts their effects, whereas GM-CSF peaked in the evening [45, 46] . However, whether the circadian rhythm of DNA synthesis and colony forming capability in the bone marrow are modulated by glucocorticoids or soluble cytokines has not been reported using loss-of-function or gain-of-function analyses. Interestingly, there is some evidence that melatonin, a neuroendocrine hormone synthesized from a tryptophan precursor in the pineal gland in the latter part of the night in both humans and rodents, might affect the progenitor capability of the rat bone marrow. These authors found that pinealectomy performed in the previous afternoon ablated the biphasic bone marrow CFU-GM peaks at 06 : 00 and 18 : 00, and the oscillations were rescued by administration of melatonin [47] .
Possible contribution from an intrinsic oscillator
It has been reported that murine CFU-GM activity in culture peaked at 09 : 00 circadian time independent of the time of harvest [27] . In addition, ablation of the SCN did not perturb the 24-h hour rhythms of bone marrow cell cycle distribution or progenitor activity [21] . Taken together, these two studies suggest that an autonomous and self-sustaining bone marrow oscillator contributes to circadian variations in bone marrow activity. Oscillations in Per1, Per2, and Cry2 expression have been described in human CD34 þ progenitor cells [48] . Recent studies have analyzed the expression of clock genes in the murine bone marrow. Quantitative real-time reverse transcription PCR studies have demonstrated the expression of clock genes in HSC-enriched Hoechst 33342-excluding side population [12] and sorted Lin À Sca-1 þ c-kit þ cells (S. Mé ndez-Ferrer and P.S. Frenette, unpublished observation). However, expression of clock genes in the bone marrow does not seem to follow rigorously organized circadian oscillations [10 ,11] . Although our studies have shown an oscillatory trend for Bmal1, Clock, Per1, Per2, Cry1, and Rev-erb-a mRNA levels in total bone marrow, these fluctuations were not statistically significant. This might be attributable to the heterogeneity in the bone marrow compartment, with heterogeneous patterns in different cell types. Nonetheless, the pattern of mRNA oscillations were noticeably different when photic cues were changed from 12 : 12 light-darkness to constant light or 12 : 12 darkness-light (jet lag), suggesting that the peripheral oscillators in the bone marrow are entrained by the SCN. Conclusive studies with selective modification of clock gene expression in the bone marrow will be needed to distinguish the respective roles of the central clock and a putative bone marrow oscillator.
Circadian oscillations in hematopoietic stem cell/progenitor egress from the bone marrow
Previous studies from our group have demonstrated that the SNS is required for both physiological and enforced egress of HSC/progenitors from the bone marrow. G-CSF-induced mobilization of progenitor cells from the bone marrow is dependent on SNS-mediated downregulation of Cxcl12 and is enhanced by b 2 -adrenergic agonists [49] . Human CD34 þ cell migration, proliferation, and mobilization are promoted by norepinephrine and epinephrine through b 2 -adrenergic activation directly on CD34 þ cells [50] . Unforced, physiological release of HSCs into the circulation is not random or steady but instead follows circadian oscillations. These oscillations are dependent on sympathetic signaling through the b 3adrenergic receptors expressed by bone marrow stromal cells, which leads to Cxcl12 mRNA downregulation probably via degradation of the transcription factor Sp1 (Fig. 2) [10 ] . These circadian oscillations are regulated by the molecular clock as Bmal1 À/À mice did not show fluctuations in circulating progenitors, and normal oscillations were entrained by light. Pharmacological sympathectomy with 6-OHDA abrogated fluctuations of circulating HSCs and local denervation of the bone marrow abolished fluctuations in the expression of Cxcl12 in the bone marrow. The Cxcl12 gene promoter contains consensus E-box sequences, which raised the possibility of direct regulation by a peripheral oscillator. However, primary bone marrow stromal cultures from Bmal1 À/À and Per1 À/À Per2 m/m mice downregulated Cxcl12 in response to stimulation with isoproterenol (a nonselective b-adrenergic agonist), similar to control cultures. The mouse Cxcl12 promoter also contains binding sites for Sp transcription factors, which are highly conserved in humans. Mutations in the proximal Sp site in the human [51] or mouse (D. Lucas and P.S. Frenette, unpublished observation) promoters ablated constitutive Cxcl12 transcription, suggesting a key role for this family of transcription factors in steady-state CXCL12 levels in the bone marrow. Indeed, treatment of primary bone marrow stromal cultures and the reticular fibroblastic stromal cell line, MS-5, with mithramycin A, an inhibitor of the binding of Sp transcription factors to DNA, significantly downregulated Cxcl12 expression. Pharmacological activation of b-adrenergic receptors rapidly reduced Sp1 nuclear content in MS-5 cells [10 ] , an effect that was only partially prevented with the proteasome inhibitor MG132 (S. Mé ndez-Ferrer and P.S. Frenette, unpublished observation). Interestingly, other studies have revealed that Sp1 degradation induced by treatment with the progenitor-mobilizing agent lipopolysaccharide also leads to Cxcl12 downregulation that is mediated by a trypsin-like serine protease [52] . In conclusion, these studies indicate that rhythmic HSC release is likely controlled by clock genes in the SCN and transduced by the SNS innervation into the bone marrow.
In humans, progenitors were also reported to fluctuate in a circadian manner, with an initial study suggesting a morning acrophase but subsequent studies indicating that the peak was the evening [10 ,53-56,57 ] (Table 2) . Thus, nocturnal mice and diurnal humans have inverted cycles of progenitors, with peaks coinciding with their resting period. These rhythms are conserved in mice after enforced mobilization with G-CSF [57 ] . In addition, expression levels of chemokine (C-X-C motif) receptor 4, the cognate receptor for chemokine (C-X-C motif) ligand 12, also fluctuated on HSCs, and these oscillations depended on Bmal1 expression. These data therefore suggest that a coordinated expression of chemokine and ligands regulates the steady-state traffic of HSCs. 
Conclusion
These studies clearly demonstrate circadian changes in HSC/progenitor cell proliferation and trafficking in the bone marrow. Why does HSC function oscillate in a circadian manner? Although there is no definitive answer to this question, the peak of circulating HSC counts in the resting period of both mice (light phase) and humans (darkness) suggests a possible role in the regeneration of the stem cell niche, or perhaps, more broadly, of extramedullary tissues, or of both. Interestingly, HSCs and progenitors constitutively traffic in the bloodstream to multiple tissues and have been suggested to differentiate in extramedullary tissues [58] [59] [60] . Additionally, the rhythmic proliferation patterns likely have physiological importance as Per2-deficient mice have a high frequency of lymphomas attributed to reduced apoptosis in damaged cells [61] . Even if much remains to be learned about the biological function and mechanisms, there are important practical and clinically relevant conclusions that can be drawn from these studies and hopefully soon applied to the clinic. For example, the circadian effects on cell proliferation may have important implications in cancer therapy. Over 30 anticancer agents have been studied for chronobiological oscillations in efficacy and toxicity in rodents [62] , and clinical trials using circadianguided infusions of chemotherapies have reported promising results [3] . On the basis of recent studies, we would expect that the egress of human HSCs from the bone marrow is maximal in the evening, and the return (homing) to the bone marrow is predicted to peak in the morning. Consistent with this possibility, a retrospective analysis of G-CSF-mobilized patients has revealed a higher stem cell yield in patients harvested later during the day [57 ] . Thus, prospective studies are needed to assess whether the timing of the stem cell harvest and the subsequent infusion can impact the yield and engraftment, respectively. As one says, time will tell.
